References
- Lass-Flörl C. Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy. Expert Rev. Anti Infect. Ther.8(2), 127–135 (2010).
- Lehrnbecher T, Groll AH. Invasive fungal infections in the pediatric population. Expert Rev. Anti Infect. Ther.9(3), 275–278 (2011).
- Oz Y, Kiraz N. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods. Expert Rev. Anti Infect. Ther.9(3), 289–298 (2011).
- Zaoutis T. Candidemia in children. Curr. Med. Res. Opin.26(7), 1761–1768 (2010).
- Steinbach WJ. Pediatric aspergillosis: disease and treatment differences in children. Pediatr. Infect. Dis. J.24(4), 358–364 (2005).
- Şensoy G, Belet N. Invasive Candida infections in solid organ transplant recipient children. Expert Rev. Anti Infect. Ther.9(3), 317–324 (2011).
- Özen M, Dündar NO. Invasive aspergillosis in children with hematological malignancies. Expert Rev. Anti Infect. Ther.9(3), 299–306 (2011).
- Salman N, Törün SH, Budan B, Somer A. Invasive aspergillosis in hematopoietic stem cell transplantation and solid organ transplantation. Expert Rev. Anti Infect. Ther.9(3), 307–315 (2011).
- Kuyucu N. Amphotericin B use in children: conventional and lipid-based formulations. Expert Rev. Anti Infect. Ther.9(3), 357–367 (2011).
- Somer A, Törün SH, Salman N. Caspofungin therapy in immunocompromised children and neonates. Expert Rev. Anti Infect. Ther.9(3), 347–355 (2011).
- Tap?s?z A. Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections? Expert Rev. Anti Infect. Ther.9(3), 339–346 (2011).
- Türel O. Newer antifungal agents. Expert Rev. Anti Infect. Ther.9(3), 325–338 (2011).
- Steinbach WJ. Critical importance of antifungal dosing in children. Expert Rev. Anti Infect. Ther.9(3), 283–284 (2011).
- Maschmeyer G. Invasive fungal disease: better survival through early diagnosis and therapeutic intervention. Expert Rev. Anti Infect. Ther.9(3), 279–281 (2011).